The hub proteins identified, CAT, PLEKHA4, HSP90AB1, TXN, EEF2, H6PD, and PDIA3, may play important roles in the treatment of gastric cancer using nintedanib (Fig. 6). This evidence concerns the gene TXN and gastric cancer.